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ABSTRACT 
 
Analysis of Ghrelin Concentrations in Serum  
Samples Processed at One, Two, and  
Three Hours after Collection  
  
by 
 
Christine Prato  
 
Dr. Mark Buttner, Examination Committee Chair 
Associate Professor of Environmental and Occupational Health  
University of Nevada, Las Vegas  
 
Obesity is becoming an epidemic of modern society. While the health-related 
consequences of obesity have been well studied, scientists continue to search for 
biological risk factors associated with this disease. Since the 1999 discovery of an 
appetite-stimulating hormone, ghrelin, researchers have further questioned the 
physiological interactions that lead to obesity. The fundus of the stomach, as well the 
intestines and kidneys produce ghrelin before it circulates throughout the body and 
attaches to its receptor sites located within the section of the brain responsible for 
appetite-regulation. The hormone increases and decreases in a circadian rhythm that may 
dictate the routine human eating patterns of breakfast, lunch and dinner.  
While the field of ghrelin research continues to grow as evidenced by the 
increasing number of published articles, the majority of the ghrelin research occurs in the 
laboratory setting. This environment has provided researchers with the preservation and 
storage techniques necessary to analyze ghrelin. For example, the current Millipore 
Human Ghrelin (Total) ELISA kit protocol for measuring ghrelin requires the coll cted 
blood be centrifuged thirty minutes after collection and immediately placed in a freezer. 
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This limitation alone may impede researchers wishing to conduct clinical research 
because these requirements are frequently not possible.  
The objectives of this study were to determine the optimal storage time before
processing blood samples collected in the clinical setting to ensure the preservation of 
ghrelin and to conclude whether a change in the manufacturer’s protocol was warrnted.  
By comparing blood samples processed according to the Millipore ELISA kit 
protocol to samples stored for one, two, and three hours, it was determined that mean 
ghrelin concentrations at thirty minutes, one hour and two hour were not significantly 
different, suggesting that the current Millipore ELISA protocol of thirty minutes can be 
extended for a period of up to two hours.  
When the crude model was adjusted to include the variables time, waist 
circumference and exercise, the statistically significant variables in previous ANOVA 
models, the presence or absence of an exercise routine was found to have the strongest
association to mean ghrelin concentrations. These findings will facilitate the xperimental 
design of research aimed at studying ghrelin levels in individuals outside of th  
laboratory setting, and can also support new research analyzing the effect of exercise on 
ghrelin levels.  
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CHAPTER 1 
 
INTRODUCTION  
 
Obesity is the second leading cause of preventable death in the U.S. and it is 
estimated that almost 100 million adults in this country have a body mass index over 25 
(CDC, 2002). Combating obesity has been a main objective of the CDC for several years. 
As part of the Healthy People 2010 initiative, the CDC hoped that obesity rates would 
decrease to 15% of the population in each state; however, no state met that objective 
(CDC, 2009). The causes of obesity can be subdivided into environmental and biological 
factors. A decrease in physical exercise combined with a high caloric intake accounts for 
the majority of obesity cases. However, biological factors such as metabolic dis rders 
like Prader-Willi syndrome, and imbalances in the various proteins that surround food 
intake and digestion, if not managed properly, can also lead to obesity.  
This disease is also of great concern for public health officials since it is often 
cited for the great number of associated co-morbidities. Cardiovascular disese, Type II 
diabetes, certain types of cancer, and sleep apnea can all result from being obese (Bray, 
2004). The direct medical costs associated with obesity are staggering. The impact of 
obese patients seeking medical attention stresses the US healthcare system since an obese 
patient can require the care of numerous physicians, while being prescribed various
medications. This utilization of the available healthcare resources due to obesity cost 
$147 billion in 2008 (Hammond, 2010). However, the consequences of obesity are not 
just limited to health related outcomes; it also places strain on other aspects of daily life.  
In addition to the direct medical costs associated with this disease, obesity affec s 
the nation by causing loss of productivity, human capital, and increasing the cost of
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transportation (Hammond, 2010). While members of the population who are normal 
weight may not currently be affected by the increasing levels of obesity in the nation, the 
stresses that obesity places on the infrastructure of American lifestyles as well as the U.S. 
healthcare system are serious consequences that were once overlooked.  
Fortunately for those individuals seeking to lose weight, there are numerous 
dietary, behavioral, pharmacological and surgical interventions that have proven to be 
successful weight loss strategies. While all programs distinctly advertise themselves, the 
basic premise of burning more calories than one consumes prevails. For individuals who 
accept the challenge of taking strides toward a healthier lifestyle, weight loss and a 
decrease in the risk factors for co-morbidities are the awards. However, onc one reaches 
an ideal weight, maintaining the new weight proves difficult. Even the most optimistic 
data report that only twenty percent of those who lose ten percent or more of their ini ial 
body weight do not regain that weight for at least one year (Wing, 2005). Since a larg
proportion of people can not sustain their weight loss goals, investigating long-term 
weight loss maintenance is critical to our nation’s health.  
In 1999 researchers identified a hormone that may contribute to weight regain. 
Ghrelin attaches to a region in the brain responsible for inducing feelings of hunger 
(Wren, 2001) and the concentration of ghrelin peaks prior to the routine meal pattern of 
breakfast, lunch and dinner (Cummings, 2001). Furthermore, circulating ghrelin levels
are suppressed in obese individuals and elevated in underweight individuals (Tschop, 
2001; Shiiya, 2002). This inverse proportion of weight and ghrelin is intuitively logical. 
An obese person does not need to consume a similar amount of calories as the 
underweight individuals since the obese person has fat reserves which the body can 
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utilize for energy. However, when obese individuals lose weight, some data suggest that 
ghrelin levels may elevate to concentrations disproportionate to the individuals’ new 
weight (Hansen, 2002). This increase in ghrelin levels triggers a stimulus for food-intake 
that ultimately combats the positive results of weight loss. Although there is an emerging 
body of data evaluating ghrelin levels in weight-loss maintainers in controlled laboratory 
environments (Cummings, 2001; Cummings, 2002; Tanofsky-Kraff, 2007), descriptive 
data collected in the non-laboratory environment are limited.  
Hosoda (2004) completed the first study aimed at characterizing ghrelin stab lity. 
While his sample size and experiments were limited, his findings have impacted the 
collection and handling of blood samples used to analyze ghrelin concentrations.  Today, 
collecting blood samples in a laboratory setting specifies quick preservation including the 
addition of 0.1 N HCl to prevent ghrelin degradation, and storage as recommended by 
Hosoda (2004), and outlined by the ELISA protocols used to analyze ghrelin 
concentrations in humans.  
Accurate evaluation of the impact of ghrelin on weight regain in the clinical 
setting requires a reliable method for the collection, processing, and storage of samples 
following blood collection. While blood may be immediately preserved, processed and/or
frozen in laboratory studies, this is not the case with research occurring in the cli ical
setting. The existing Millipore Human Ghrelin (Total) ELISA kit protocol for measuring 
ghrelin concentrations require that blood be centrifuged thirty minutes after collection 
and immediately placed in a freezer. In clinical research, collection of the sample and 
transportation to a laboratory to process the sample can frequently not be completed 
within the time limits of the protocols. Thus current guidelines for processing samples 
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may be deterring researchers interested in evaluating ghrelin in non-laboratory settings, 
and ultimately stalling the future of translational research in this field.  
An extensive search in literature databases has revealed that there are no 
published research reports that specifically evaluate stability of ghrelin in blood samples 
in the clinical setting.  Measuring ghrelin concentrations in the clinical setting makes it 
virtually impossible to immediately preserve and store samples since the transportation of 
centrifuges and freezers are unrealistic.  Because trends in ghrelin concentrations 
following attainment of goal weight will provide a foundation for interpreting the 
significance of post-weight loss ghrelin concentrations, it is critical to evaluate the 
accuracy of ghrelin concentrations measured in the clinical setting. To do this, ghrelin 
concentrations determined according to strict observance of the existing protocol will be 
compared to ghrelin concentrations measured at time periods longer than recommended.  
Purpose of the Study 
 
The objectives of this study are: (1) to analyze the serum ghrelin concentrations in 
blood after storage at 4°C for thirty minutes, one hour, two hours, and three hours and 
(2), to conclude based on the aforementioned findings whether a change in the 
manufacturer’s protocol is warranted.   
If findings suggest that blood samples collected to determine ghrelin 
concentrations can indeed be stored for periods of time beyond the manufacturer’s 
recommendation of thirty minutes, the effects will be far-reaching. First, the ability to 
compare data collected in the clinical setting to published data obtained in the laboratory 
environment will confirm that ghrelin research is indeed translational. If findings differ 
between the two settings there exists the possibility that current ghrelin research is not 
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capturing the spectrum of both environmental and biochemical interactions that influence 
circulating ghrelin concentrations.  Since no published studies have yet to investigate the 
effect of storage time on mean ghrelin concentrations as detected in an ELISA assay, this 
novel research will also lead to a more defined characterization of ghrelin stability. 
Additionally, positive findings related to increased storage time, may attract future 
researchers to this field that were once limited by storage time in research design.  
While manufacturers of kit protocols, such as the one provided by Millipore, have 
scientific and legal reasons for not providing the scientists using the kits with a ra ionale 
for the processing guidelines, scientists need to understand how changes among the 
protocols may affect the outcome of a study.  Since no studies have yet to determine he 
effect of time on mean ghrelin concentrations, it is unclear whether the few clinical 
ghrelin research studies are reporting skewed data since Type II error may have been 
inadvertently entered in to the study design.   
Research Questions 
 
H0: There will be no statistically significant differences in mean ghrelin 
concentrations among blood samples stored for one, two, or three hours after collection 
compared to the samples analyzed according to the Millipore protocol.  
The aforementioned time intervals represent realistic storage times that a 
researcher may experience in the clinical setting. Factors such as transport tion, access to 
a centrifuge, and the number of patients being evaluated are all concerns in constructing 
study designs.  
H0: The variables height, weight, and waist circumference will exhibit a positive, 
significant correlation to mean ghrelin concentrations. 
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It is expected to see that the variables which are well known for correlating to 
mean ghrelin concentrations as evidenced in previous, laboratory research will rema n
statistically significant in this research (r > 0.5, p < 0.1).   
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
Researchers first identified the natural ligand, ghrelin, for the growth hormone 
secretagogue receptor in 1999 (Kojima, 1999). The binding of ghrelin releases growth
hormone into the body which then binds to receptors that regulate energy balance in the 
brain. Ghrelin has been identified as a hunger-stimulating hormone (Wren, 2001) and is 
now considered the most important and powerful orexigenic hormone currently 
recognized (Asakawa, 2001). Ghrelin is found in an active, acyl, and unactive, desacyl, 
form in the human body (Hosoda, 2000) and degrades into the desacyl form. Desacyl 
ghrelin is relatively stable, and can be exposed to various storage conditions including 
high pH and temperature, and remain stable (Hosoda, 2004). The majority of research 
(Hosoda, 2000; Cummings, 2001; Cummings, 2002) has quantified total ghrelin since 
Ariyasu (2002) reported a lack in marked discrepancies between desacyl and acyl forms.  
In addition, it is the only orexigenic hormone that stimulates food ingestion, 
regardless of other physiologic or environmental cues for eating or satiety (Asakawa, 
2001). Existing ghrelin research focuses on the biological effects of the hormone 
(Cummings, 2001; Cummings, 2002; Tschop, 2001; Tschop, 2002). Research performed 
by Cummings et al (2002) has provided insight into the factors that determine hunger. 
This hormone may also play an important role in understanding and combating the 
obesity epidemic since ghrelin concentrations are weight dependent (Tschop, 2001; 
Shiiya, 2002). Hansen (2002) concluded that when an obese person loses weight, post-
weight loss ghrelin concentrations surpass ghrelin concentrations found in normal-weight 
individuals. This biological response to weight loss may prove instrumental in 
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understanding the difficulties of weight maintenance as well as the factors involved in 
weight gain.  
However, to date, the majority of the ghrelin research has taken place in 
laboratory settings.  While this setting allowed scientists to quickly process and quantify 
ghrelin samples (Cummings, 2001; Cummings, 2002; Natalucci, 2005), the research takes 
place under specific guidelines that are not applicable to everyday life. New transla ional 
research aims to investigate whether previously reported ghrelin trends (Cummings, 
2001; Cummings, 2002) are observable in clinical settings. In stark contradiction to 
preprandial and postprandial ghrelin trends reported by Cummings et al (2001 & 2002), 
in unpublished, recently completed research, Sally Miller failed to find a statistic lly 
significant decrease between preprandial and postprandial ghrelin concentrations in the 
clinical setting. The inability to find a similar trend in subjects measured in two settings 
raises the issue of the importance of proper handling and processing techniques 
concerning ghrelin. Current ELISA manufacturer protocols for measuring ghrelin require 
that blood be centrifuged and frozen within thirty minutes of collection. In clinica  
research, this is frequently not possible. 
Unlike aforementioned ghrelin research that occurred in a laboratory setting, 
blood samples collected in the clinical environment may sit for hours before processing 
can occur. Thus, it is imperative to understand how various processing methods can 
affect the stability of ghrelin.  
In 2004, Hosoda revealed that ghrelin is most stable at pH 4 and recommended a 
10% addition of 1 M HCl to the sample to achieve the greatest stability of the acyl side 
chain. In this literature review, the research lacked a comparison between 0.05 N HCl, 
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Millipore’s recommended acidification, and 0.1 N HCl which may lead to further 
preservation research.  
Additionally, Hosoda (2004) recommends chilling and centrifuging the sample 
within 30 minutes. Groschl (2002) and Staes (2010) both report the stability of ghrelin at 
4ºC, a condition satisfied by placing collection tubes in an ice chest until processing can 
occur; however, guaranteed immediate access to a centrifuge in the clinical setting is 
unrealistic. While this previous research has provided an introduction in to ghrelin 
stability, one must also consider the small samples sizes utilized in the studies. Hosoda 
(2004) only collected samples from three participants, while Groschl (2002) has a larger 
sample size of sixteen individuals. Groschl ultimately subdivided the participants to study 
different storage conditions.  
While the initial research into the field of ghrelin has provided current research 
with important findings, there exists a myriad of research questions to be investigat d.  
Based on the findings of this literature review, more research into the time-sensitive 
degradation of ghrelin performed using blood samples from a larger sample size is 
needed to better understand how to process collection tubes before centrifugation. If 
storage times do not significantly affect ghrelin concentrations over tim, researchers 
may begin to expand ghrelin research to incorporate the clinical setting.  
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CHAPTER 3 
 
METHODOLOGY  
 
This research study involved the participation of human subjects, and as such the 
researcher applied for IRB approval to ensure the protection of research subject  
throughout the research process. Subjects were assigned non-identifiable numbers, and 
the only forms that contained the subjects’ identities were stored in a separate location 
than the forms containing any identifying information such as date of birth and age. 
Obtaining subject consent implied informing the subjects of the voluntary nature of 
participation as well as the risks, compensation, and benefits of participation.    
Recruitment for the research participants was limited to females aged 30 to 60 
years. This demographic was necessary to complete other arms of the study tha  did not 
affect the outcome of the data reported in this thesis. This study included women within 
the 30 to 60 year old range, who were currently not pregnant, did not begin a weight loss 
program or started a new exercise schedule within the previous thirty days. Numerous 
factors such as the number of participants used in previous published literature related to 
ghrelin stability, and the financial constraints of the grant, limited the number of total 
research subjects to twenty six. The researcher did not use formal methods of 
recruitment, but rather relied on word of mouth and both inter-and intradepartmental 
emails to advertize the study among the university campus. Additionally, professors 
within the University of Nevada, Las Vegas, School of Nursing informed students who 
met the inclusion and exclusion criteria. As all arms of the research were novel, the 
assumption was made that the demographics on the university campus were 
representative of the average female.  
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Collection of Data 
Once a participant was consented and enrolled into the study as dictated by the 
IRB approval, she reported to the Bigelow Health Science building on the University of 
Nevada, Las Vegas campus in the morning following an overnight fast, which excluded 
the consumption of water since previous research has shown that water does not 
influence ghrelin concentrations in the body. The data of height, weight, waist 
circumference, last menstrual cycle, ethnicity, marital status, regular consumption of 
breakfast, medications, vitamins and/or supplements, and the presence or absence of an 
exercise routine was collected. To protect against variations in different instruments, the 
same Weight Watchers Conair WW70 Electronic Body Fat Scale was used to w ight all 
research subject to one decimal point. Height and waist circumference were measured to 
the closest half inch.  
Next, a certified and licensed phlebotomist used a combination 21 gauge needle 
and vacutainer to collect four, 2.5 mL blood samples in to serum separator tubes. The 
phlebotomist selected a vein located within the nook of the elbow or the hand of the 
participant. Following venipuncture each blood sample was preserved with 1 mg/mL of 
Pefabloc in accordance with the Millipore Human Ghrelin (Total) ELISA kit 
recommendations to prevent ghrelin degradation. The tubes were labeled to include the 
participant’s identification number. 
The first tube was stored for thirty minutes according to the Millipore protocol.  
The remaining three tubes were labeled “1hr,” “2hr,” and “3hr,” and stored in a cooler at 
4ºC  for 1, 2, and 3 hours, respectively, before being centrifuged, acidified with 0.05 N 
HCl, and stored in accordance with the manufacturer recommendations.  Processing of 
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the blood sample was delayed for a later day, but within the guidelines of protocol 
outlined by the manufacturer.  
Treatment of Data 
The ghrelin concentrations of each blood sample was found using the Millipore 
Human Ghrelin (Total) ELISA kit (Catalog# EZGRT-87K). The samples processed 
according to the Millipore protocol and the samples stored for one, two, and three hours 
were analyzed using the aforementioned ELISA assay. Samples collected from each 
participant at each time interval were measured in triplicate to increase the assay 
reliability of the study. The final step in the ELISA assay required the use of a 
spectrophotomer which analyzed the samples at different wavelengths to determin  
ghrelin concentrations in pg/mL. The software associated with the spectrophotomer used 
in this research produces the equation used to determine ghrelin concentration levels i  
each sample. The software then provided mean ghrelin concentrations (pg/mL) for each 
participant at each time interval. These data were analyzed using SPSS version 18.0 
statistical programs to determine whether to reject or fail to reject the null hypotheses.   
 First, the variable of time was categorized as a factor, and divided in to its four 
levels: baseline (30 minutes), 1 hour, 2 hour and 3 hours. Since time acted as the 
independent variable in this model, a repeated measures analysis of variance test was 
used to determine the effect of time on the dependent variable, mean ghrelin 
concentrations. Initially, time was entered as a main effect in the model, an a crude 
repeated measures analysis of variance was performed. Because the variabl , time, was 
found to be significant, a Least Significant Difference post hoc test allowed the 
researcher to determine which time groups significantly differed from each other.  
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 Next, the researchers ran an adjusted analysis of variance test using the variabl s 
that were assessed prior to the collection of the blood samples. The multicollinearity of 
the variables was determined using a correlation test within the SPSS version 18.0 
software. Multicollinear variables (r > 0.5, p < 0.01) were entered in to the adjusted 
repeated measures analysis of variance test separately. Again, time served as the 
independent variable, while mean ghrelin concentration acted as the dependent variable. 
All of the other variables collected were entered in to the model as covariates. The 
significance variables found while running these adjusted models were incorporated in to 
a final adjusted model to determine the statistically significant variables involved in 
predicting mean ghrelin concentrations.  
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CHAPTER 4 
FINDINGS OF THE STUDY 
In twenty six females aged 30 to 60 years, the effect of time played a statistically 
significant (p < 0.1) role in determining mean ghrelin concentrations. A LeastSignificant 
Difference test determined that the mean ghrelin concentrations in samples stored for 
thirty minutes, one hour, and two hour differed statistically compared to the mean ghreli  
concentrations recovered at the three hour storage time. However, when an adjusted 
model incorporating the variables height, weight, waist circumference, last menstrual 
cycle, ethnicity, marital status, consumption of breakfast, medications, vitamins nd/or 
supplements, and the presence or absence of an exercise routine was ran, variablesother 
than time were also significantly associated with mean ghrelin concentrations.  
The final adjusted model included the statistically significant variables time, waist 
circumference and presence or absence of an exercise routine, but found that the presenc  
or absence of an exercise routine was the only statistically significance association with 
mean ghrelin concentration. 
Analysis of Data 
Table 1 shows the demographics of the sample population. Caucasians 
represented 80.7% (n= 21) of the sample while three Hispanics constituted 11.5%, and 
the remaining two subjects were Asian American. Eighteen subjects identified as 
married, while five subjects were single, and three subjects were divorced. The majority 
of the sample (n=17) associated into a pre-menopausal state, and 84.6% (n=22) normally  
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Table 1.  
 
Demographics and Characteristics of the Twenty-Six, Female Participants Aged 30-60 
Years.  
Variable N % 
Gender   
     Female  26 100 
Age    
     30-45 14 53.8 
     46-60 12 46.2 
Height (in)   
    59- 66 17 65.4 
    67-72 9 34.6 
Weight (lbs)   
        110-140.9 6 23.1 
        141-175.9 8 30.8 
        176-200 5 19.2 
        200-250 4 15.4 
        250-300 3 11.5 
Waist Circumference (in)   
        29-35 14 53.8 
        35.5- 40 6 23.1 
        40- 45.5  6 23.1 
Marital Status   
         Married 18 69.2 
         Single 5 19.2 
         Divorced 3 11.5 
Ethnicity   
        Caucasian 21 80.8 
        Hispanic 3 11.5 
        Asian American 2 7.7 
Pre-menopausal    
         Yes 17 65.4 
         No  9 34.6 
Normally eat breakfast   
        Yes  22 84.6 
        No 4 15.4 
Take medications   
       Yes 12 46.2 
       No 14 53.8 
Take vitamins or supplements    
       Yes 14 53.8 
       No 12 46.2 
Routine Exercise schedule   
       Yes 13 50 
       No 13 50 
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ate breakfast. Half of the women did not have a routine exercise schedule (n=13), and 
less than half reported taking either medications or supplements.   
While the between subject ghrelin concentrations differ by as much as 1,200 
pg/mL, the within subject concentrations grouped at similar concentrations (Table 2). 
Since this analysis aimed to identify the effect of time on individual’s ghrelin 
concentrations, the between subject differences did not bias the analysis. Missing data 
points resulted when the ELISA assay did not detect ghrelin concentrations. As a result, 
subject number 23 was removed from the dataset, and the baseline mean concentration 
value of subject number 25 was substituted with the ghrelin concentration recovered at 1 
hour.  
The data in Table 2 are also displayed in the format of a bar graph in Figure 1. 
The mean ghrelin concentrations (pg/mL) found in Table 2 served as the template to 
perform the crude repeated measures analysis of variance to determine the eff ct of time 
on mean ghrelin concentrations recovered at the baseline, one hour, two hours, and three 
hours.  
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Table 2.  
 
Ghrelin Concentrations (pg/mL) of Twenty-Five Female Participants Aged 30-60 Years 
Analyzed at 4ºC at Four Time Points: 30 Minutes, 1 Hour, 2 Hour, and 3 Hour. 
Subject 
Number 
[Ghrelin] at  30 
minutes 
[Ghrelin] at 
1 hour 
[Ghrelin]at 
2 hour 
[Ghrelin] at 
3 hour 
1 1618.9 1109.0 1615.9 1119.8 
2 995.1 1260.3 1032.7 391.4 
3 686.7 756.3 615.9 529.3 
4 381.1 681.9 353.3 383.0 
5 479.9 575.4 528.1 472.1 
6 1702.5 1852.6 1535.5 1423.3 
7 568.9 507.9 566.1 526.2 
8 688.9 841.9 882.3 722.4 
9 665.8 775.4 839.5 956.0 
10 1008.4 987.5 833.6 793.9 
11 903.0 596.5 580.8 779.8 
12 717.5 375.5 511.8 372.9 
13 516.9 314.5 519.3 446.6 
14 290.2 359.6 205.8 189.2 
15 1155.4 1498.6 958.3 1205.6 
16 187.4 380.7 285.8 170.2 
17 984.7 1409.7 926.9 957.3 
18 444.9 293.9 422.1 408.0 
19 681.3 824.9 751.6 634.1 
20 1025.4 1109.1 1244.6 1255.6 
21 252.4 364.8 389.3 391.3 
22 963.5 909.1 862.0 987.8 
24 373.6 458.8 482.6 442.6 
25 331.5 331.5 303.0 207.9 
26 2771.1 2636.9 2537.1 1981.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A bar graph depicting the mean 
storage time intervals: baseline (30 minutes), one hour, two hour, and three hours. 
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± 5% error bars ghrelin concentrations at each 
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Statistical Analysis of Research Questions 
The data found in Table 2 served as the template to perform a crude repeated measures 
analysis of variance to determine the effect of time on mean ghrelin concentrations at 
baseline (30 minutes), one hour, two hours and three hours. Because subject number 23 
did not have three out of the four data point, the data were excluded in the statistical 
portion of this research. Additionally, because a baseline point from subject 25 was not 
recovered, the mean ghrelin concentration found at the one hour storage time also served 
as the baseline value. 
As seen in Table 3, this model yielded four levels related to the factor, time: 
baseline (30 minutes), one hour, two hour and three hours. Each factor contained the 
dependent variable of ghrelin concentration (pg/mL). A statistically insignificant 
Mauchly’s test of sphericity (p > 0.05) confirms that sphericity is maintained, and thus 
directs the researcher to the correct values to interpret. These data did not have a 
statistically significant Mauchly test of sphericity (Mauchly’s W = 0.630, p = 0.062). 
 
Table 3.  
The Categorization of the Four Levels of Time Generated by the Repeated Measures 
ANOVA, and the Mean Ghrelin Concentrations (pg/mL) Recovered at Each Level of Time 
with Their Respective Standard Deviations.   
Within-Subjects Factors 
Levels of time Dependent 
Variable 
[ghrelin] 
Mean ghrelin 
concentrations (pg/mL) 
Standard Deviation 
1 baseline 815.8044 563.92793 
2 1 hour 848.5118 558.86906 
3 2 hour 791.3658 515.57120 
4 3 hour 709.9261 440.04356 
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This information allowed the researcher to interpret the sphericity assumed column on the 
test of within subject effects which demonstrated in Table 3 that the various time points 
showed a statistically significant effect of time (Table 4; F= 3.643, p= 0.017). 
 
Table 4.  
The Effect of Time is Significant in the Crude Repeated Measures ANOVA.  
Test of Within-Subjects Effects 
Source  F Sig 
Factor 1 Sphericity Assumed 3.643 0.017* 
Note. * = p ≤  0.1 
 
From this test, the Least Significant Difference (LSD) post-hoc test wa  used to 
determine which groups statistically differed from each other (Table 5).  
 
Table 5.  
 
Pairwise Comparisons Using the Least Significant Difference Post Hoc Test to 
Determine which Storage Times Statistically Differ (p < 0.1) from Each Other.  
Time level being analyzed Compared to the time 
levels 
Sig 
3 hour 30 minutes .041* 
 1 hour .014* 
 2 hour .063* 
Note.* = p ≤  0.1 
 
 
The small sample size combined with the conservative nature of this the LSD post hoc 
test justified interpreting significance at p < 0.1. Mean ghrelin concentrations (Table 3) in 
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the baseline, one hour, and two hour groups demonstrated statistical differences, p = 
0.041, p = 0.014, and p = 0.063 respectively, from mean ghrelin concentrations in 
samples stored for 3 hours (Table 5).  
To avoid entering mutilcollinearity in to the model, a bivariate statistical 
correlation was analyzed for the four variables: exercise, height, weight and waist 
circumference. With r > 0.5 and p < 0.01, the correlations between height, weight and 
waist circumference were significant (Table 6). This finding supports performing three 
separate models to analyze the effect of height, weight and waist circumference.  Next, 
the first of three adjusted models was analyzed using a repeated measure an lysis of 
variance test to determine if any of the following variables significantly competed with 
the effect of time on mean ghrelin concentrations:  
 
Table 6.  
 
Analysis of the Correlation of the Variables: Height, Weight, and Waist Circumference.  
 Weight Waist 
Circumference 
Height 
Weight 
 
Pearson 
Correlation (r) 
 
Sig (p) 
 
1 
 
.916** 
 
 
.000 
 
.692** 
 
 
.000 
Waist 
Circumference 
Pearson 
Correlation 
 
Sig 
 
.916** 
 
 
.000 
 
1 
 
.524** 
 
 
.007 
Height Pearson 
Correlation 
 
Sig 
 
.692** 
 
 
.000 
 
.524** 
 
 
.007 
 
1 
Note. ** = r > 0.5, and p ≤  0.01.  
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age, waist circumference, marital status, ethnicity, pre-menstrual satus, ethnicity, 
breakfast consumers, users of prescribed medications and supplements and presence or 
absence of an exercise schedule in her lifestyle. Table 7 shows the test of between-subject 
effects which assesses the significance of each variable entered in to the model. The 
 
Table 7.  
The Test of Between-Subjects Effects Analyzes the Effect of Covariates on th  Impact of 
Time in the Repeated Measures Analysis of Variance. Waist Circumference is the Only 
Statistically Significant Variable.  
Between-Subject Effects 
Variable F Sig (p) 
 
Waist circumference 
 
3.213 
 
0.095* 
Note. * = p ≤  0.1  
 
small sample size of n= 25 and the exploratory nature of this research allowed the 
researcher to interpret significance at p < 0.1. Table 7 shows only one variable, waist  
circumference, to be significant (p = 0.095). Another repeated measures analysis of 
variance test was then performed removing the variable, waist circumference, and 
replacing it with the variable, weight (Table 8). None of the variable was statitic lly 
significant (p > 0.1).   
 
Table 8.  
The Test of Between-Subjects Effects Analyzed the Effect of Potential Covariates on the 
Impact of Time in the Repeated Measures Analysis of Variance.  
Between-Subjects Effects 
Variable F Sig 
 
Weight 
 
3.019 
 
0.103 
 
 
 
23
 
Lastly, researchers substituted the variable, height, in the repeated measures analysis of 
variance test to determine what effect, if any, it had on mean ghrelin concentrations 
measured at different time intervals. Table 9 shows that while the variable, height, did not 
impact the dependent variable (p = 0.953) the variable, exercise, demonstrated a 
significant p – value (p = 0.061).  
 
Table 9.  
The Test of Between-Subjects Effects Analyzes the Effect of Potential Covariate, Height, 
on the Impact of Time in the Repeated Measures Analysis of Variance.  
Between-Subjects Effects 
Variable F Sig 
 
Presence or absence of 
exercise routine 
 
4.056 
 
.061* 
Note. * = p ≤ 0.1.  
 
 
With the findings that two variables had a statistically significant impact (p <0.1) on the 
dependent variable, mean ghrelin concentration, an adjusted model was used to determine 
the effect of waist circumference and exercise on 
time when entered in to a repeated measures ANOVA.  
The test of within-subject effect in Table 10 shows that the variable, time, is no 
longer a significant variable in the model (F= 1.013, p = 0.392). While both waist 
circumference and exercise proved significant predictors during the modeling process, 
the between-subjects effects in Table 10 shows that only the variable, exercise, r mained 
statistically significant in the adjusted model (F = 4.725, p = 0.041).  
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Table 10.  
 
The Adjusted Repeated Measures Analysis of Variance Test of Within-Subject Effects 
Measured the Effect of Time on Mean Ghrelin Concentrations (pg/mL) while the 
Between-Subjects Effect Analyzed the Association between Potential Covariates on M an 
Ghrelin Concentrations (pg/mL).  
Test of Within-Subjects Effects Between-Subject Effects 
Variable  F Sig Variable F Sig 
 
Time 
 
 
Sphericity 
Assumed 
 
1.013 
 
0.392 
 
Waist 
Circumference 
 
2.586 
 
.122 
     
Presence or 
absence of 
exercise routine 
 
4.725 
 
.041* 
Note. * = p ≤ 0.1 
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CHAPTER 5 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
The statistical technique used to analyze the mean ghrelin concentration over the 
four storage periods of 30 minutes, one hour, two hour and three hours concluded that 
there were statistically significant (p < 0.1) differences among the mean ghrelin 
concentrations. In the crude model the null hypothesis was rejected and a post-hoc te t 
utilizing least significant difference (LSD) was implemented to determine which of the 
time periods were statistically significant. Ultimately, the mean ghrelin concentrations 
recovered at the three hour storage time were concluded to be statistically less than the 
thirty minute, one hour and two hour mean ghrelin concentrations.  
The final adjusted model revealed that exercise had the strongest association with 
mean ghrelin concentrations even when adjusted for time and waist circumference. The 
impact of exercise on mean ghrelin concentration plays a more significant role than time 
if it is entered as a covariate in the model.   
The two objectives of this study included (1) analyzing ghrelin levels in blood 
samples allowed to sit for thirty minutes, one hour, two hours and three hours before 
processing according to a manufacturer’s ELISA kit and (2) concluding based on the 
aforementioned findings whether a change in the manufacturer’s protocol is warranted. 
The results that suggest the mean ghrelin concentrations recovered after thirty minutes do 
not differ statistically between samples stored for two hours accomplished this goal. This 
research can serve as an initial argument for amending storage protocols within the 
ELISA assay; however, future studies will need to be conducted before changes to the 
existing protocol are considered.  
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Discussion of Results 
The demographics of the participants of this study were 80.8% Caucasian (n = 
21), 11.5% Hispanic (n = 3) and two subjects or 7.7 % of the sample was Asian American 
(Table 1). The majority of the participants were married (n = 18), while only 3 subjects 
were divorced, and 5 were single (Table 2). The ELISA assay did not detect ghrelin
concentrations for four data points. Because three of the missing data points were found 
among the samples provided by one subject, 23, the data did not contribute to the 
statistical analysis of the data. For the last missing data point, the baseline m an 
concentration value for subject number 25 was replaced with the mean ghrelin 
concentration recovered at 1 hour.  The increase at 1 hour among some of the samples 
was an unexpected phenomenon. While one can only hypothesize about the increase in 
ghrelin concentrations during this time interval, it is most likely the result of assay 
variability, and perhaps human error involved in loading the 96 well plates. The mean 
ghrelin concentrations and their standard deviations (Table 3) were depicted in a bar
graph (Figure 1), to allow for a visual representation of the task of determining if the 
mean ghrelin concentrations were far enough apart to state that the mean ghrelin 
concentrations statistically differed at various points in time.    
When the data were entered in to the statistical software for analysis, the program 
categorized the independent variable, time, in to four levels: baseline, 1 hour, 2 hour and 
three hour (Table 3). Overall, the findings of the crude repeated measures ANOVA found 
time to be a significant variable in mean ghrelin concentrations (Table 4). A Least
Significant Difference post hoc test revealed that mean ghrelin concentratio s among the 
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thirty minute, one hour and two hour time intervals did not differ by a statistically 
significant amount (Table 5). 
Next, the multicollinearity of the variables weight, height, waist circumference 
and exercised were assessed. Because the variables waist circumference, weight and 
height were found to be multicollinear ( r > 0.5, p < 0.01 ) in Table 6, these three variable 
were entered in to the adjusted repeated measures ANOVA found in Tables 7, 8, and 9, 
respectively. Only the variable, waist circumference, proved to be statistically significant 
(Table 7). However, Table 9 which analyzed the effect of height on the model showed the 
presence or absence of an exercise routine to be a statistically significant vari ble (p < 
0.1). When the three significant variables time, waist circumference and the presence or 
absence of an exercise routine were entered in to the adjusted repeated measures 
ANOVA (Table 10), the presence or absence of an exercise routine proved to have the 
most significant association with mean ghrelin concentrations.  
While the findings of this study will benefit many researchers wishing to expand 
the current realm of ghrelin research, there were some limitations that affected the final 
outcome.  
A study can only analyze as many subjects as the funding can support, and this 
study is a testament to those financial restrictions. While a sample size of twenty five 
subjects was larger than any previously reported sample size used to study ghrelin 
stability, it may not be large enough to determine the actual trends of ghrelin degradation 
over time.  
Additionally, the sample size is too small to make generalizations about the 
overall population; however, the findings supported here provide an initial step in 
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learning more about the effects of storage conditions of this appetite stimulating 
hormone.  
Participants were asked to complete this study while in a fasted state, and it is 
possible that ghrelin concentrations could not be recovered in subject number 23 due to 
consumption of food or beverages before the blood collection. In a more ideal setting, the 
researcher would be able to confirm that food intake does not occur before taking 
samples to ensure that ghrelin concentrations can be detected.  
Furthermore, while the goal was to centrifuge and acidify blood samples at the 
indicted times, there were occasions when the processing of samples was delayed by five 
to ten minutes. In future studies, the ability to be precise while processing the sample 
should be taken in to account. In addition, the need to minimize human error and increase 
assay validity as other aspects to be considered in future studies.  
Conclusions and Recommendations for Further Study 
The crude repeated measures ANOVA showed that mean ghrelin concentrations 
at thirty minutes, one hour and two hour did not differ statistically. This finding could 
allow future researchers wishing to observe ghrelin in the non-traditional, cliical setting, 
to go in to the field to collect samples from a broad range of subjects. Prior to these 
findings, researchers were limited to just thirty minutes to collect and preserve th  
sample, as well as transport the specimen to a centrifuge to be processed. The crude 
findings alone will positively impact the field of translational ghrelin research.  
With increased storage times scientists studying ghrelin can design and implement 
research in the clinical setting. Collecting data in this environment will give scientists 
greater insight into the effect ghrelin has on individuals acting in their routine setting . 
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The ability to perform translational research will positively impact the current knowledge 
base regarding ghrelin, and its effect on obesity. Ultimately, future research on ghrelin 
could prove instrumental in helping individuals maintain weight loss, prevent obesity, 
and reduce the risk of co-morbidities related to this epidemic. 
The field of research related to ghrelin is vast, and results of new experiments are 
continually being published. In this specific area a similar study could be expanded to 
include both female and male participants over the age of 18, and process samples more 
frequently, such as every fifteen minutes, instead of the thirty and sixty minute intervals 
used in this research. Additionally, an increased sample size may elucidate the effect of 
variables that researchers expected to be significant, such as waist circumference, and 
weight. As researchers learn more about the optimal preservation of ghrelin, t y can 
continue to lift design limitations that have previously constricted research of this 
hormone.  
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APPENDIX 1 
IRB APPROVAL 
 
 
 
31
APPENDIX 2 
MILLIPORE HUMAN GHRELIN (TOTAL) ELISA KIT PROTOCOL 
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